BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2787833)

  • 1. Screening of congenital hypothyroidism, phenylketonuria, galactosemia, homocystinuria, and maple syrup urine disease in moderate to severe mentally retarded Chinese children.
    Hsiao KJ; Chen CH; Liu TT; Wu SJ; Plettner C; Clemens P
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):18-22. PubMed ID: 2787833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening: the role of the obstetrician.
    Larsson A; Therrell BL
    Clin Obstet Gynecol; 2002 Sep; 45(3):697-710; discussion 730-2. PubMed ID: 12370609
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal screening for congenital disorders.
    Gudat JC; Maclaren NK
    J Fla Med Assoc; 1980 Feb; 67(2):137-42. PubMed ID: 7359105
    [No Abstract]   [Full Text] [Related]  

  • 4. State screening for metabolic disorders in newborns.
    Stevens MB; Rigilano JC; Wilson CC
    Am Fam Physician; 1988 Apr; 37(4):223-8. PubMed ID: 3358346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls of newborn screening (with special attention to hypothyroidism): when will we ever learn?
    Holtzman NA
    Birth Defects Orig Artic Ser; 1983; 19(5):111-20. PubMed ID: 6411141
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory examinations for inborn errors of metabolism].
    Kawamura M
    Rinsho Byori; 1986 Feb; 34(2):133-5. PubMed ID: 3702083
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for inherited metabolic diseases and congenital hypothyroidism in 4,744 mentally retarded school children in Taiwan.
    Wuu KD; Hsiao KJ; Chen CH; Hsiao TS; Chang CY; Chu YK
    Jinrui Idengaku Zasshi; 1988 Mar; 33(1):33-40. PubMed ID: 3392841
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal screening in Italy for congenital hypothyroidism and metabolic disorders: hyperphenylalaninemia, maple syrup urine disease and homocystinuria.
    Antonozzi I; Dominici R; Andreoli M; Monaco F
    J Endocrinol Invest; 1980; 3(4):357-63. PubMed ID: 7204885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for metabolic and endocrine diseases.
    Tiwary CM
    Nurse Pract; 1987 Sep; 12(9):28-35, 38, 41. PubMed ID: 3118277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].
    Bozkowa K; Cabalska B; Radomyska B; Ołtarzewski M; Lenartowska I
    Med Wieku Rozwoj; 1999; 3(4):529-59. PubMed ID: 10910678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for congenital metabolic disorders. Indication and results].
    Bickel H
    Monatsschr Kinderheilkd; 1983 Jun; 131(6):323-7. PubMed ID: 6888386
    [No Abstract]   [Full Text] [Related]  

  • 12. [25 years Austrian screening program for inborn errors of metabolism at the Vienna University].
    Widhalm K
    Wien Klin Wochenschr; 1992; 104(16):510-3. PubMed ID: 1413809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study of a nation-wide neonatal metabolic screening program in Japan. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan.
    Tada K; Tateda H; Arashima S; Sakai K; Kitagawa T; Aoki K; Suwa S; Kawamura M; Oura T; Takesada M
    Eur J Pediatr; 1984 Aug; 142(3):204-7. PubMed ID: 6468444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for metabolic disorders. How are we doing?
    Irons M
    Pediatr Clin North Am; 1993 Oct; 40(5):1073-85. PubMed ID: 8414711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a state-wide neonatal screening programme.
    Robertson EF; Hill GN; Pollard AC
    Med J Aust; 1979 May; 1(9):365-7. PubMed ID: 314036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of newborn infants in Norway for severe metabolic disease].
    Pettersen RD; Saugstad OD; Heyerdahl S; Motzfeldt K; Lie SO
    Tidsskr Nor Laegeforen; 1995 Feb; 115(5):584-7. PubMed ID: 7900109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INBORN ERRORS OF METABOLISM.
    FINCKE ML
    J Am Diet Assoc; 1965 Apr; 46():280-4. PubMed ID: 14285451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening newborn infants for phenylketonuria, histadinemia, homocystinuria and maple syrup disease. Results from north rhein-westphalia (1974-1976) (author's transl].
    Menne F; Otte HJ; Krüger M; Winterhoff D
    MMW Munch Med Wochenschr; 1978 May; 120(18):619-22. PubMed ID: 306535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up of patients with inborn errors of metabolism detected by the newborn screening program in Japan.
    Aoki K
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():19-23. PubMed ID: 15906687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of the Westphalia-Lippe newborns of 1977 for phenylketonuria, histidinemia, homocystinuria and maple syrup disease. Furthermore a pilot study of galactosemia and galactokinase deficiency disease].
    Menne F; Otte HJ; Krüger M; Winterhoff D
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):833-4. PubMed ID: 111089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.